NCT02212119View on ClinicalTrials.gov

Safety and Effectiveness of Botulinum Toxin in Elderly Patients With Dementia and Muscle Stiffness

PHASE2CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

February 28, 2013

Study Completion Date

January 31, 2014

Conditions

DementiaParatonia

Interventions

DRUG

Botulinum Toxin

DRUG

Saline

Trial Locations (1)

M6A 2E1

Assistive Technology Clinic at Baycrest, Toronto

Sponsors

Collaborators (1)

Merz Pharmaceuticals GmbH

All Listed Sponsors

collaborator

Merz Pharmaceuticals GmbH

INDUSTRY

collaborator

Baycrest

OTHER

lead

Assistive Technology Clinic, Canada

OTHER

NCT02212119 - Safety and Effectiveness of Botulinum Toxin in Elderly Patients With Dementia and Muscle Stiffness | Biotech Hunter | Biotech Hunter